RT Journal Article
SR Electronic
T1 Two new compartmental epidemiological models and their equilibria
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.03.21263050
DO 10.1101/2021.09.03.21263050
A1 Balisacan, Jonas
A1 Chyba, Monique
A1 Shanbrom, Corey
YR 2021
UL http://medrxiv.org/content/early/2021/09/07/2021.09.03.21263050.abstract
AB Compartmental models have long served as important tools in mathematical epidemiology, with their usefulness highlighted by the recent COVID-19 pandemic. However, most of the classical models fail to account for certain features of this disease and others like it, such as the ability of exposed individuals to recover without becoming infectious, or the possibility that asymptomatic individuals can indeed transmit the disease but at a lesser rate than the symptomatic. Furthermore, the rise of new disease variants and the imperfection of vaccines suggest that concept of endemic equilibrium is perhaps more pertinent than that of herd immunity.Here we propose a new compartmental epidemiological model and study its equilibria, characterizing the stability of both the endemic and disease-free equilibria in terms of the basic reproductive number. Moreover, we introduce a second compartmental model, generalizing our first, which accounts for vaccinated individuals, and begin an analysis of its equilibria.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe second author is supported by NSF grant 2030789.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a